Nasdaq
$23.96▲ 0.71%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.79BShares out 74.7M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
5- 9.21After-hours26.09.22 06:154Ownership#●●●
Schrodinger, Inc.
Karen Akinsanya, an executive at Schrodinger, Inc., filed a Form 4 report on September 21, 2026, regarding a change in beneficial ownership of company securities that occurred on September 17, 2026.…more
$23.96+0.71%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.17After-hours26.09.18 05:27144Ownership
Schrodinger, Inc.
Karen Akinsanya, an executive at Schrodinger, Inc., has filed an SEC Form 144 to report the proposed sale of company shares. This is a standard disclosure regarding an insider's plan to dispose of their holdings.…more
$23.96+0.71%vs prev closeView filingShare - 8.5After-hours26.08.06 05:20S-8Offering
Schrodinger, Inc.
슈뢰딩거(Schrodinger, Inc.)는 2022년 주식 보상 계획(Equity Incentive Plan)에 따라 300만 주의 보통주를 신규 발행하기 위한 S-8 등록 서류를 제출했습니다. 이번 신규 발행 주식의 최대 총액은 약 4,530만 달러 규모이며, 임직원 대상 주식 보상 목적으로 사용될 예정입니다.…more
$23.96+0.71%vs prev closeView filingShare
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.9Pre-market26.09.09 20:02#●●●#●●●
Schrödinger Announces Formation of Tectora and $55M Series A Funding
Schrödinger has co-founded a new biotechnology company, Tectora, alongside NEA and RA Capital Management to focus on immunology and inflammation therapies. Schrödinger contributed two early-stage programs in exchange for an equity stake and potential future milestone payments and royalties.…more
$23.96+0.71%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga